Reduction in disability in a randomized controlled trial of telephone-administered cognitive-behavioral therapy.

OBJECTIVE The authors examined the efficacy of telephone-administered cognitive-behavioral therapy (T-CBT) and telephone-administered supportive emotion-focused therapy (T-SEFT) in reducing disability among disabled patients with multiple sclerosis and depression. Telephone administration of therapy allowed care to be delivered to a more disabled population. This is a secondary analysis of a randomized controlled trial; the primary outcome results for depression are reported in D. C. Mohr, S. L. Hart, L. Julian, C. Catledge, L. Honos-Webb, L. Vella, et al. (2005). DESIGN A randomized controlled trial, comparing 16 weeks of T-CBT with T-SEFT. MAIN OUTCOME MEASURES Disability was measured using Guy's Neurological Disability Scale; fatigue was measured using the Fatigue Impact Scale; depression was measured using the Hamilton Depression Rating Scale and the Beck Depression Inventory-II. RESULTS Patients in both treatments showed significant improvements in disability and fatigue. These improvements were related to reductions in depression. T-CBT produced significantly greater decreases in disability and fatigue, compared with T-SEFT, even after controlling for depression. The greater benefit of T-CBT on disability was mediated by physical fatigue. CONCLUSION These findings support the hypothesis that significant reductions in disability can be achieved by reducing depression in patients with multiple sclerosis. There was also evidence that further reductions could be achieved through CBT-specific interventions that include a focus on symptoms such as fatigue management.

[1]  David C Mohr,et al.  Telephone-administered psychotherapy for depression. , 2005, Archives of general psychiatry.

[2]  S. Patten,et al.  Major depression in multiple sclerosis , 2003, Neurology.

[3]  J. Watson,et al.  Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. , 2003, Journal of consulting and clinical psychology.

[4]  D. Mohr,et al.  Effects of Treatment for Depression on Fatigue in Multiple Sclerosis , 2003, Psychosomatic medicine.

[5]  F. Kraaimaat,et al.  Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial , 2002, Pain.

[6]  M. T. J. Buñuales,et al.  La clasificación internacional del funcionamiento de la discapacidad y de la salud (CIF) 2001 , 2002 .

[7]  H. Kraemer,et al.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.

[8]  D. Mohr,et al.  Multiple sclerosis: empirical literature for the clinical health psychologist. , 2001, Journal of clinical psychology.

[9]  B. Sharrack,et al.  The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis , 1999, Multiple sclerosis.

[10]  Frederick A. Stich,et al.  A meta-analysis of outcome studies comparing bona fide psychotherapies: Empiricially, "all must have prizes." , 1997 .

[11]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[12]  J. Oger,et al.  Depression and multiple sclerosis , 1996, Neurology.

[13]  Leslie S. Greenberg,et al.  Facilitating Emotional Change: The Moment-by-Moment Process , 1995 .

[14]  D. Mohr Negative Outcome in Psychotherapy: A Critical Review , 1995 .

[15]  R M Kaplan,et al.  The Ziggy theorem: toward an outcomes-focused health psychology. , 1994, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[16]  Gary M. Klein,et al.  Differences in Illness Intrusiveness Across Rheumatoid Arthritis, End-Stage Renal Disease, and Multiple Sclerosis , 1993, The Journal of nervous and mental disease.

[17]  H. Kraemer Reporting the size of effects in research studies to facilitate assessment of practical or clinical significance , 1992, Psychoneuroendocrinology.

[18]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[19]  John DeLuca,et al.  Fatigue as a window to the brain. , 2005 .

[20]  L. Krupp,et al.  Multiple Sclerosis and Fatigue. , 2005 .

[21]  D. Mohr,et al.  Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. , 2000, Journal of consulting and clinical psychology.

[22]  David C Mohr,et al.  Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis , 1998 .

[23]  J. Beck,et al.  Cognitive Therapy: Basics and Beyond , 1995 .

[24]  T. Marrie,et al.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  P. Kendall,et al.  Cognitive-behavioral interventions , 1994 .

[26]  K. Wells,et al.  A structured interview version of the Hamilton Depression Rating Scale: evidence of reliability and versatility of administration. , 1990, Journal of psychiatric research.

[27]  A. O'Leary,et al.  A cognitive-behavioral treatment for rheumatoid arthritis. , 1988, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[28]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.